The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor

Journal of Ocular Pharmacology and Therapeutics

Volumn 12, Issue 3, 1996, Pages 363-376

  Sugrue, Michael F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXY 2 BENZOTHIAZOLESULFONAMIDE; 6 HYDROXY 2 BENZO[B]THIOPHENESULFONAMIDE; 6 PIVALOYLOXY 2 BENZOTHIAZOLESULFONAMIDE; ACETAZOLAMIDE; BENZOTHIAZOLE DERIVATIVE; CARBONATE DEHYDRATASE INHIBITOR; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; L 651465; L 668931; METHAZOLAMIDE; SEZOLAMIDE; TIMOLOL; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; AQUEOUS HUMOR OUTFLOW; DOSE RESPONSE; DRUG PENETRATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TISSUE LEVEL; ENZYME INHIBITION; EYE BLOOD FLOW; EYE IRRITATION; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NONHUMAN; OPEN ANGLE GLAUCOMA; ORAL DRUG ADMINISTRATION; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0029809816     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1996.12.363     Document Type: Review

References (41)

1. Wistrand, P.J. Carbonic anhydrase in the anterior uvea of the rabbit. Acta Physiol. Scand., 24:144-148, 1951.
2. Lütjen-Drecoll, E., Lönnerholm, G., and Eichhorn, M. Carbonic anhydrase distribution in the human and monkey eye by light and electron microscopy. Graefe's Arch. Clin. Exp. Ophthalmol., 220:285-291, 1983.
3. Wistrand, P.J., Schenholm, M., and Lönnerholm, G. Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest. Ophthalmol. Vis. Sci., 27:419-428, 1986.
4. Maren, T.H. The development of ideas concerning the role of carbonic anhydrase in the secretion of aqueous humor: relation to the treatment of glaucoma. In Glaucoma: Applied Pharmacology in Medical Treatment, Drance, S.M. and Neufeld, A.H., eds., Grune and Stratton, Inc., Orlando, 1984, pp. 325-355.
5. Becker, B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox. Am J. Ophthalmol., 37:13-14, 1954.
6. Grant, W.M. Antiglaucoma drugs. Problem with carbonic anhydrase inhibition. In Symposium on Ocular Therapy, Leopold, I.H., ed., C.V. Mosby, St. Louis, 1973, pp. 19-38.
7. Epstein, D.L. and Grant, W.M. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch. Ophthalmol., 95:1378-1382, 1977.
8. Schwam, H., Michelson, S.R., Sondey, J.M., and Smith, R.L. L-645,151, a topically effective ocular hypotensive carbonic anhydrase inhibitor: Part 1. Biochemistry and metabolism. Invest. Ophthalmol. Vis. Scl., 25 Suppl: 180, 1984.
9. Sugrue, M.F., Gautheron, P., Schmitt, C., Viader, M.P., Conquet, P., Smith, R.L., Share, N.N., and Stone, C.A. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor. J. Pharmacol. Exp. Ther., 232:534-540, 1985.
10. Bar-Ilan, A., Pessah, N.I., and Maren, T.H. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151. J. Ocular Pharmacol., 2:109-120, 1986.
11. Woltersdorf, O.W., Schwam, H., Bicking, J.B., Brown, S.L., deSolms, S.J., Fishman, D.R., Graham, S.L., Gautheron, P.D., Hoffman, J.M., Larson, R.D., Lee, W.S., Michelson, S.R., Robb, C.M., Share, N.N., Shepard, K.L., Smith, A.M., Smith, R.L., Sondey, J.M., Strohmaier, K.M., Sugrue, M.F., and Viader, M.P. Topically active carbonic anhydrase inhibitors. I. O-Acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide. J. Med. Chem., 32:2486-2492, 1989.
12. Werner, E.B., Gerber, D.S., and Yoder, Y.L. Effect of a topical carbonic anhydrase inhibitor, 6-hydroxybenzo[b]thiophene-2-sulfonamide, on intraocular pressure in normotensive subjects. Can. J. Ophthalmol., 22:316-319, 1987.
13. Lippa, E.A. The eye: topical carbonic anhydrase inhibitors. In The Carbonic Anhydrases. Dodgson, S.J., Tashian, R.E., Gros, G., and Carter, N.D., eds., Plenum Publishing Corp., New York, 1991, pp. 171-181.
14. Graham, S.L., Shepard, K.L., Anderson, P.S., Baldwin, J.J., Best, D.B., Christy, M.E., Freedman, M.B., Gautheron, P., Habecker, C.N., Hoffman, J.M., Lyle, P.A., Michelson, S.R., Ponticello, G.S., Robb, C.M., Schwam, H., Smith, A.M., Smith, R.L., Sondey, J.M., Strohmaier, K.M., Sugrue, M.F., and Varga, S.L. Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activity. J. Med. Chem., 32:2548-2554, 1989.
15. Lee, V.H.L. and Robinson, J.R. Review: topical ocular drug delivery: recent developments and future challenges. J. Ocular Pharmacol., 2:67-108, 1986.
16. Baldwin, J.J., Ponticello, G.S., Anderson, P.S., Christy, M.E., Murcko, M.A., Randall, W.C., Schwam, H., Sugrue, M.F., Springer, J.P., Gautheron, P., Grove, J., Mallorga, P., Viader, M.-P., McKeever, B.M., and Navia, M.A. Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. J. Med. Chem., 32:2510-2513, 1989.
17. Mallorga, P., Reiss, E.R., Ponticello, G.S., Baldwin, J.J., and Sugrue, M.F. Binding of the carbonic anhydrase inhibitor MK-927 to ocular pigment Invest. Ophthalmol. Vis. Sci., 30 Suppl:445, 1989.
18. Sugrue, M.F., Gautheron, P., Grove, J., Mallorga, P., Viader, M.P., Schwam, H., Baldwin, J.J., Christy, M.E., and Ponticello, G.S. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor. J. Ocular Pharmacol., 6:9-22, 1990.
19. Lippa, E.A., von Denffer, H.A., Hofmann, H.M., and Brunner-Ferber, F.L. Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor. Arch. Ophthalmol., 106:1694-1696, 1988.
20. Bron, A.M., Lippa, E.A., Hofmann, H.M., Feicht, B.I., Royer, J.G., Brunner-Ferber, F.L., Panebianco, D.L., and Von Denffer, H.A. MK-927: a topically effective carbonic anhydrase inhibitor in patients. Arch. Ophthalmol., 107:1143-1146, 1989.
21. Lee, P.-Y., Podos, S.M., Howard-Williams, J.R., Severin, C.H., Rose, A.D., and Siegel, M.J. Pharmacological testing in the laser-induced monkey glaucoma model. Curr. Eye Res., 4:775-781, 1985.
22. Wang, R.-F., Serie, J.B., Podos, S.M., and Sugrue, M.F. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys. Curr. Eye Res., 9:163-168, 1990.
23. Hartman, G.D., Halczenko, W., Prugh, J.D., Smith, R.L., Sugrue, M.F., Mallorga, P., Michelson, S.R., Randall, W.C., Schwam, H., and Sondey, J.M. Thieno[2,3-b]furan-2-sulfonamides as topical carbonic anhydrase inhibitors. J. Med. Chem., 35:3027-3033, 1992.
24. Sugrue, M.F., Mallorga, P., Schwam, H., Baldwin, J.J., and Ponticello, G.S. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals. Curr. Eye Res., 9:607-615, 1990.
25. Wistrand, P.J. and Knuuttila, K.-G. Renal membrane-bound carbonic anhydrase. Purification and properties. Kidney Intl., 35:851-859, 1989.
26. Hageman, G.S., Zhu, X.L., Waheed, A., and Sly, W.S. Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. Proc. Natl. Acad. Sci. USA, 88:2716-2720, 1991.
27. Wolfensberger, T.J., Mahieu, I., Jarvis-Evans, J., Boulton, M., Carter, N.B., Nógrádi, A., Hollande, E., and Bird, A.C. Membrane-bound carbonic anhydrase in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci., 35:3401-3407, 1994.
28. Ridderstråle, Y., Wistrand, P.J., and Brechue, W.F. Membrane-associated CA activity in the eye of the CA II-deficient mouse. Invest. Ophthalmol. Vis. Sci., 35:2577-2584, 1994.
29. Murakami, M., Sears, M.L., Mori, N., Mead, A., Horio, B., and Yamada, E. The loci of carbonic anhydrase activity in the ciliary epithelium of the rabbit eye: electrophysiological study with isolated ciliary epithelial bilayer. Acta Histochem. Cytochem., 25:77-85, 1992.
30. Sugrue, M.F., Waheed, A., Sly, W.S., Baldwin, J.J., Habecker, C.N., Lumma, W.C., Schwam, H., and Sondey, J.M. A study of the in vitro inhibition of human carbonic anhydrase isoenzymes I, II and IV. Invest. Ophthalmol. Vis. Sci., 34 Suppl:930, 1993.
31. Maren, T.H., Wynns, G.C., and Wistrand, P.J. Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme. Mol. Pharmacol., 44:901-905, 1993.
32. Wang, R.-F., Serle, J.B., Podos, S.M., and Sugrue, M.F. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys. Arch. Ophthalmol., 108:511-513, 1990.
33. Wang, R.-F., Serie, J.B., Podos, S.M., and Sugrue, M.F. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch. Ophthalmol., 109:1297-1299, 1991.
34. Vareilles, P. and Lotti, V.J. Effect of timolol on aqueous humor dynamics in the rabbit. Ophthalmic Res., 13:72-79, 1981.
35. Friedland, B.R. and Maren, T.H. Carbonic anhydrase: pharmacology of inhibitors and treatment of glaucoma. In Pharmacology of the Eye, Sears, M.L., ed., Springer-Verlag, Berlin, 1984, pp. 279-309.
36. Sugrue, M.F. and O'Neill-Davis, L. The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits. J. Ocular Pharmacol., 7:201-211, 1991.
37. Alm, A. and Bill, A. The oxygen supply to the retina, II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol. Scand., 84:306-319, 1972.
38. Alm, A. and Bill, A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res., 15:15-29, 1973.
39. Sugrue, M.F. and Ludden, C. The effect of topical ocular hypotensive carbonic anhydrase inhibitors on regional ocular blood flow in albino rabbits. Invest. Ophthalmol. Vis. Sci., 32 Suppl:1186, 1991.
40. Gordon, L.R., Bailly, Y., Durand-Cavagna, G., and Peter, C.P. Preclinical findings in ocular irritation studies with dorzolamide hydrochloride. Exp. Eye Res., 59 Suppl 1:S29, 1994.
41. Maren, T.H. The development of topical carbonic anhydrase inhibitors J. Glaucoma, 4:49-62, 1995.